BSE filing, NSE: BOMOXY-B1. Summary written from the filing by ALFA Finder's alert engine.
Bombay Oxygen Investments Ltd: key numbers
- Share price
- ₹16,700.00
- Market cap
- ₹250.5 Cr
- Revenue (annual)
- ₹-1.96 Cr
- Net profit (annual)
- ₹-3.24 Cr
- P/E (TTM)
- 238.6×Sector 19.7×
- Promoter holding
- 73.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bombay Oxygen Investments Ltd
All →Bombay Oxygen Investments Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is in compliance with SEBI listing regulations.
Bombay Oxygen Investments Annual General Meeting
Bombay Oxygen Investments Limited conducted its 65th Annual General Meeting on August 25, 2026. Shareholders considered the adoption of financial statements and the declaration of a dividend.
Bombay Oxygen Investments Regulatory Approval
Bombay Oxygen Investments is applying to the RBI for voluntary surrender of its NBFC Certificate of Registration. The company will continue operations as an unregistered NBFC.
Bombay Oxygen Investments Other Announcement
Bombay Oxygen Investments Ltd will apply to the RBI to voluntarily surrender its NBFC Certificate of Registration. The company expects no material impact on business operations.
Bombay Oxygen Investments Q1 FY27 Results: Net Profit ₹28.5 Cr, Up 17.8% YoY
Bombay Oxygen Investments Ltd reported revenue from operations of ₹33.6 Cr (+16.3% YoY) and net profit of ₹28.5 Cr (+17.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹28.5 Cr · +17.8% YoY
Bombay Oxygen Investments Board Meeting Date
Bombay Oxygen Investments Ltd has scheduled a board meeting for August 10, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.
Himadri Speciality Chemical Other Announcement
Himadri Speciality Chemical's members approved an alteration of its Memorandum of Association and adoption of a new MOA under the Companies Act, 2013. The approval was by special resolution through postal ballot on October 27, 2026.